1202805-93-3

Upstream product

• 885609-84-7 N-(2-bromo-5-fluorophenyl)pivalamide 
• 1003-99-2 2-bromo-5-fluoroaniline 
• 109-04-6 2-bromo-pyridine 
• 1202805-45-5 N-[5-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2,2-dimethylpropanamide 
• 3282-30-2 pivaloyl chloride 
• 109-09-1 2-chloropyridine 

Downstream Products

• 1202805-94-4 N-[4-bromo-5-fluoro-2-(pyridin-2-yl)phenyl]-2,2-dimethylpropanamide 
• 1202805-95-5 N-[4-bromo-3-fluoro-6-(pyridin-2-yl)-2-nitrophenyl]-2,2-dimethylpropanamide 
• 1202805-96-6 4-bromo-3-fluoro-6-(pyridin-2-yl)-2-nitroaniline 
• 1372548-10-1 N-(5-bromo-4-fluoro-7-(pyridin-2-yl)benzothiazol-2-yl)benzamide 

Relevant academic research and scientific papers

ANTIBACTERIAL COMPOUNDS

The present invention provides a compound of the following formula and salts thereof: Also provided is the use of these compounds as antibacterials, compositions comprising them and processes for their manufacture.

BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS

The present invention provides Gyrase B and/or Topoisomerase IV par E inhibitors, which can be used as antibacterial agents. Compounds disclosed herein can be used for treating or preventing conditions caused by or contributed by gram positive, gram negative and anaerobic bacteria, more particularly against, for example, Staphylococci, Streptococci, Enterococci, Haemophilus, Pseudomonas spp., Acenetobacter spp., Moraxalla spp., Chlamydia spp., Mycoplasma spp., Legionella spp., Ktycobacterium spp., Helicobacter, Clostridium spp., Bacteroides spp., Coryne bacterium, Bacillus spp., Enterobactericeae,' (E.coli, Klebsiella spp., Proteus spp.,etc. ) or any combination thereof Also provided, are processes for preparing compounds disclosed herein, pharmaceutical compositions containing compounds disclosed herein, and methods of treating bacterial infections. (Formula)